BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% / NIACINAMIDE 2% / PENTOXIFYLLINE 0.5% is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Pentoxifylline; Betamethasone Dipropionate; Minoxidil; Niacinamide.
| Product ID | 72934-4024_88612417-d10c-6a2b-e053-2995a90a7266 |
| NDC | 72934-4024 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% / NIACINAMIDE 2% / PENTOXIFYLLINE 0.5% |
| Generic Name | Betamethasone Dipropionate 0.05% / Minoxidil 5% / Niacinamide 2% / Pentoxifylline 0.5% |
| Dosage Form | Solution |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-05-09 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Sincerus Florida, LLC |
| Substance Name | PENTOXIFYLLINE; BETAMETHASONE DIPROPIONATE; MINOXIDIL; NIACINAMIDE |
| Active Ingredient Strength | 2 g/100g; g/100g; g/100g; g/100g |
| Pharm Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |